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Abstract
 Hepatitis B surface antigen (HBsAg) serves as a serological marker for Hepatitis B virus (HBV) infection. People with HBV asymptomatic infection might readily donate blood due to the lack of clinical manifestations. Host immunity contributes to susceptibility and progression of infection. A polymorphism in IL-10 gene promoter, rs1800896, might contribute to host immunity. This study was conducted on May 2019–January 2020 in Faculty of Medicine, University of Riau on 70 blood samples from donors in the Indonesian Red Cross Pekanbaru. Out of these samples, 35 were reactive for HBsAg and 35 donors were nonreactive. Genotyping of rs1800896 was conducted using 
Amplification Refractory Mutation System (ARMS-PCR). In total, The distribution of AA (74.3%), AG (24.3%), 
and GG (1.4%) genotypes revealed in this study seemed to be similar to genotype distribution among East and 
South-East Asian populations. While no significant difference was observed on age mean and gender distribution, 
a significant difference was identified in  genotype distribution between HBsAg status (p-value 0.028) with the 
percentage of AA genotype was higher among HBsAg-nonreactive donors (85.7%) compared to reactive donors 
(62.9%). More studies should be conducted to characterize HBsAg-reactive blood donors, including the donor characteristics and the viral genotypes. Such studies should contribute to hepatitis B management in Indonesia.
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Distribusi Polimorfisme Promoter IL-10 pada Donor Darah 
dengan HBsAg Reaktif dan Nonreaktif di Pekanbaru
Abstrak 
Hepatitis B surface antigen (HBsAg) merupakan penanda serologis infeksi virus hepatitis B (HBV). Individu dengan infeksi HBV asimptomatik dapat melakukan donasi darah karena tidak ada gejala klinis. Imunitas inang 
berkontribusi pada kerentanan dan perkembangan infeksi. Polimorfisme pada promoter gen IL-10, rs1800896, dapat berkontribusi pada imunitas inang. Penelitian dilakukan pada bulan Mei 2019–Januari 2020 di Fakultas Kedokteran Universitas Riau. Sampel diambil adalah 70 darah donor dari Palang Merah Indonesia Pekanbaru, 35 sampel reaktif HBsAg dan 35 sampel nonreaktif. Genotipe rs1800896 dilihat berdasar atas amplification refractory 
mutation system (ARMS-PCR). Pada populasi studi ini, distribusi genotipe AA (74.3%), AG (24.3%), dan GG (1.4%) sesuai populasi Asia Timur dan Tenggara. Walaupun tidak terdapat perbedaan pada rerata umur dan distribusi 
jenis kelamin, penelitian ini menemukan perbedaan signifikan pada distribusi genotipe antar kelompok status HBsAg (p=0.028), yaitu persentase genotipe AA lebih tinggi pada kelompok donor dengan HBsAg nonreaktif 
(85.7%) dibanding dengan kelompok reaktif (62.9%). Studi lebih lanjut perlu dilakukan untuk karakterisasi donor darah dengan HBsAg reaktif, termasuk gneotipe donor dan virus. Informasi tersebut diharapkan dapat bermanfaat pada manajemen hepatitis B di Indonesia.
Kata kunci: Donor darah, hepatitis, HBsAg, IL-10, polimorfisme
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IntroductionHepatitis B surface antigen (HBsAg) is a serum biomarker for hepatitis B virus (HBV) infection. In 2013, the prevalence of HBsAg seropositivity 
in Indonesia was 7.1%, thus making Indonesia categorized as an intermediate endemic area for hepatitis B.1 Hepatitis B virus infection has various clinical manifestations, starting from asymptomatic to hepatocarcinoma. People with asymptomatic HBV infection might be unaware of their status, thus readily donate blood. Therefore, the Indonesian Red Cross (IRC) screen for HBsAg among their donors to minimize the horizontal transmission of this disease.2 The clinical outcome of HBV infection is affected by the immune response formed by host-pathogen interactions. Host immunity contributes to the susceptibility and progression of infection.3 An anti-inflammatory cytokine, IL-10, has already been shown to play a role in chronic hepatitis B pathogenesis. Literature showed that chronic hepatitis B patients had a higher IL-10 level compared to healthy controls.4 An A/G polymorphism located in the -1082 site of IL-10 gene promoter, rs1800896, affects the gene’s transcription level and, thus, IL-10 level. A lipopolysaccharide-induced ex vivo IL-10 production shows that the -1082A allele is associated with a lower IL-10 production, and the functional association is allele-dose dependent.5 Several studies have been conducted to analyze the association between the rs1800896 polymorphism and HBV infection.6-7 Therefore, this study analyzed the association between rs1800896 genotype and HBsAg status among blood donors in IRC Pekanbaru, Indonesia.
MethodsThe minimum sample size was calculated using the case-control study formula. Based on the proportion and cumulative odds ratio from literature,8 the minimum sample size required was 35 people for each group. This study was conducted from May 2019 to January 2020. Sampling was conducted on donated blood and the analysis of the blood was performed using the chemiluminescent immunoassay (CLIA) at the Blood Transfusion Unit of the Indonesian Red Cross (IRC) Pekanbaru. All HIV reactive blood samples were excluded. There were a total of 70 blood samples collected comprising of 35 HBsAg reactive samples and 35 HBsAg non-reactive samples. Demographical data of age and gender 
were retrieved. This study has been approved by the Ethical Review Board for Medicine and Health Research, Faculty of Medicine, University of Riau with the issuance of the ethical clearance No: 0.68/UN/19.5.1.1.8/UEPKK/2019.Molecular analysis was conducted at the Integrated Research Lab of the Faculty of Medicine, University of Riau, Indonesia. The genomic DNA was isolated from blood fraction 
using the Wizard DNA Purification Kit (Promega, Madison, WI, USA) according to the protocol 
with slight modifications. After initial cell lysis, the supernatant was discarded and an additional cell lysis step with 450µL Cell Lysis Solution was conducted. DNA isolates were used as the template for IL-10 gene promoter polymorphism analysis (rs1800896; -1082A>G) 
by amplification-refractory mutation system (ARMS) PCR. The PCR was conducted to identify A-to-G polymorphism at -1082 position. Primer sequences used were as described in Perrey et al.9 PCR mix composition was adapted from Perrey et al.9 with slight adjustment. PCR mix 
composition (final concentration) was 1X GoTaq Green Master Mix, 2.5 µM of each ARMS primer, and 0.5 µM of each internal control primer. PCR condition was adapted from Perrey et al.,8 which consisted of initial denaturation (1 minute, 95°C), 10 cycles of amplification I (denaturation 95°C, 15 sec; annealing 65°C, 50 sec; extension 72°C, 40 sec), 20 cycles of amplification II (denaturation 95°C, 20 sec; annealing 59ºC, 50 sec; extension 72°C, 50 sec) and final extension (72°C, 5 minutes).9 Ten µL of PCR product was 
analyzed by electrophoresis on 2% agarose, 80V, 35 minutes. Allele and genotype was concluded based on the band pattern.Statistical analyses were conducted on age, gender, and genotype distribution (SPSS software version 24). The mean age between HBsAg status was analyzed using the t-test, while gender distribution between HBsAg status was analyzed using the chi-square test. The chi-square test was conducted for genotype distribution between HBsAg status. a p-value of 
<0.05 was considered statistically significant. 
Results This study included 70 blood donors, which 
consisted of 35 (50%) HBsAg-reactive samples 
and 35 (50%) HBsAg-nonreactive samples. Table 2 presented the demographical data of sampled blood donors in IRC Pekanbaru, Indonesia. No 
significant difference was observed in mean 
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age and gender distribution between different HBsAg status. Table 3 listed the rs1800896 genotypes and alleles among blood donors in IRC Pekanbaru based on their HBsAg status. This genotype distribution follows the Hardy-Weinberg equilibrium (p2+2pq+q2=1), with p as the frequency of allele A, q as the frequency of allele G, p2 as the frequency of genotype AA, 2pq as the frequency of genotype AG, and q2 as the frequency of genotype GG. Based on the result of the chi-square analysis, there was a statistical difference in genotype distribution 
based on HBsAg status among blood donors in IRC Pekanbaru (Table 3).
DiscussionThis study performed genotyping of 70 blood donors for rs1800896 polymorphism. The genotype distribution in total study population and both HBsAg status groups followed the Hardy-Weinberg equilibrium. The low frequency of GG genotype is typical for East and Southeast 
Table 2 Demographical Data of Blood Donors in IRC Pekanbaru, Indonesia
Variable HBsAg reactive(n=35)
HBsAg nonreactive
(n=35) Total p-valueMean age±SD, year 39.54±10.88 37.26±10.79 38.4±10.84 0.381GenderMale 27 (77.1) 25 (71.4) 52 (74.3) 0.584Female 8 (22.9)   10 (28.6) 18 (25.7)
Table 1 Primers Used in This Study9
Sequence Amplicon (bp)(-1082)A 5’- ACTACTAAGGCTTCTTTGGGAA- 3’ 259G 5’- CTACTAAGGCTTCTTTGGGAG 3’Generic 5’- CAGTGCCAACTGAGAATTTGG 3’Internal controlHGHF 5’- GCCTTCCCAACCATTCCCTTA 3’ 429HGHR 5’- TCACGGATTTCTGTTGTGTTTC 3’
Table 3 Distribution of rs1800896 Polymorphism among Blood Donors in IRC Pekanbaru, 
  Indonesia




n (%)rs1800896 genotypeAA 22 (62.9) 30 (85.7) 52 (74.3)AG 13 (37.1) 4 (11.5) 17 (24.3)GG  0 (0.00) 1 (2.8) 1 (1.4)rs1800896 alleleA 57 (81.0) 64 (91.0) 121 (86.4)G 13 (19.0) 6 (9.0) 19 (13.6)
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Table 4 Comparison of rs1800896 Polymorphism Distribution among Blood Donors in IRC 
  Pekanbaru, Indonesia
Variable HBsAg reactiven (%)
HBsAg nonreactive
n (%) p-valuers1800896 genotype 0.028AA 22 (62.9) 30 (85.7)AG / GG 13 (37.1) 5 (14.3)rs1800896 allele 0.084A 57 (81.0) 64 (91.0)G 13 (19.0) 6 (9.0)
Table 5 Comparison of rs1800896 Genotype Distribution among Several Populations10
Region Population Sample size AA (%) AG (%) GG (%)South-East Asia This study 70 74.3 24.3 1.4MalaysiaBatek 25 84.0 16.0 0.0Kensiu 36 86.1 13.9 0.0Semai 42 81.0 19.0 0.0Orang Kanaq 11 0.0 100.0 0.0Lanoh 24 88.0 12.0 0.0Che Wong 26 50.0 46.2 3.8SingaporeChinese 83 95.1 4.9 0.0East Asia Hong KongChinese 100 89.0 10.0 1.0TaiwanAmi 50 96.0 2.0 2.0Atayal 50 88.0 12.0 0.0Hakka 45 93.0 7.0 0.0Yami 40 95.0 5.0 0.0Tsou 50 98.0 2.0 0.0Minnan 50 94.0 6.0 0.0South KoreaMinnan 57 74.0 26.0 0.0South Asia IndiaNorth 130 59.0 36.0 2.0Delhi 34 58.1 37.6 4.3West Asia IraqArab 224 40.8 41.3 17.9Jordan 118 42.5 51.7 5.9Africa South AfricaZulu (Natal Region) 86 33.4 57.1 9.5Europe Netherlands 107 29.0 44.0 27.0South America ArgentinaBuenos Aires 54 25.9 48.1 25.90
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Asia populations (Table 4).10 
The genotype distribution was significantly different statistically between different HBsAg status among blood donors in IRC Pekanbaru (Table 2). HBsAg-nonreactive donors had a higher frequency of AA genotypes. The meta-
analysis suggested a significant association between genotype AA of the rs1800896 polymorphism, which has a lower risk of chronic HBV infection and a higher level of HBV self-clearance following acute infection.11 The -1082A allele has a reduced IL-10 level in an allele-dose dependent manner, thus individual with homozygous AA genotype has the lowest IL-10 level.5 In a persistent viral infection, IL-10 suppresses dendritic cell antigenic presentation capacity.12 Therefore, theoretically, a lower IL-10 level in individuals with AA genotype might contribute to the lower risk of HBV persistent infection marked by the HBsAg seroreactivity.There were several limitations to our study because data on the types of donor such as 
voluntary/replacement or first-time/multiple donors were not collected. Although HIV-reactive samples were excluded, HCV and syphilis screening results were not collected in this study. However, due to the lower prevalence of HCV and syphilis in Indonesian blood donors, 
namely 0.41% and 0.77% respectively,2 these 
co-infections would not significantly biased the results of this study. Future studies should be conducted to analyze rs1800896 polymorphism among hepatitis B patients and various serum biomarkers, especially serum IL-10. 
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